{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T01:56:48Z","timestamp":1768701408341,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,4,18]],"date-time":"2010-04-18T00:00:00Z","timestamp":1271548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s00216-010-3673-0","type":"journal-article","created":{"date-parts":[[2010,4,17]],"date-time":"2010-04-17T13:26:32Z","timestamp":1271510792000},"page":"1605-1615","source":"Crossref","is-referenced-by-count":54,"title":["Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma"],"prefix":"10.1007","volume":"397","author":[{"given":"Ana","family":"Fortuna","sequence":"first","affiliation":[]},{"given":"Joana","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Gilberto","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Am\u00edlcar","family":"Falc\u00e3o","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcio","family":"Soares-da-Silva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,4,18]]},"reference":[{"key":"3673_CR1","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1515\/CCLM.2004.245","volume":"42","author":"HM Neels","year":"2004","unstructured":"Neels HM, Sierens AC, Naelaerts K, Scharp\u00e9 SL, Hatfield GM, Lambert WE (2004) Therapeutic drug monitoring of old and newer anti-epileptic drugs. Clin Chem Lab Med 42:1228\u20131255","journal-title":"Clin Chem Lab Med"},{"key":"3673_CR2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","volume":"49","author":"PN Patsalos","year":"2008","unstructured":"Patsalos PN, Berry DJ, Bourgeois BFD, Cloyd JC, Glauser TA, Johannessen SI, Leppik IE, Tomson T, Perucca E (2008) Antiepileptic drugs\u2014best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 49:1239\u20131276","journal-title":"Epilepsia"},{"key":"3673_CR3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0404.2009.01218.x","volume":"120","author":"A Gil-Nagel","year":"2009","unstructured":"Gil-Nagel A, Lopes-Lima J, Almeida L, Soares-da-Silva P (2009) Efficacy and safety of 800 and 1200\u00a0mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures. Acta Neurol Scand 120:281\u2013287","journal-title":"Acta Neurol Scand"},{"key":"3673_CR4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00007691-199502000-00008","volume":"17","author":"VL Lanchote","year":"1995","unstructured":"Lanchote VL, Bonato PS, Campos GM, Rodrigues I (1995) Factors influencing plasma concentrations of carbamazepine and carbamazepine-10, 11-epoxide in epileptic children and adults. Ther Drug Monit 17:47\u201352","journal-title":"Ther Drug Monit"},{"key":"3673_CR5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1472-8206.2001.00055.x","volume":"15","author":"E Perucca","year":"2001","unstructured":"Perucca E (2001) Clinical pharmacology and therapeutic use of the new antiepileptic drugs. Fundam Clin Pharmacol 15:405\u2013417","journal-title":"Fundam Clin Pharmacol"},{"key":"3673_CR6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3109\/00498258609043567","volume":"16","author":"H Sch\u00fctz","year":"1986","unstructured":"Sch\u00fctz H, Feldmann KF, Faigle JW, Kriemler HP, Winkler T (1986) The metabolism of 14C-oxcarbazepine in man. Xenobiotica 16:769\u201378","journal-title":"Xenobiotica"},{"key":"3673_CR7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0009-9236(99)90061-9","volume":"66","author":"A Volosov","year":"1999","unstructured":"Volosov A, Xiaodong S, Perucca E, Yagen B, Sintov A, Bialer M (1999) Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects. Clin Pharmacol Ther 66:547\u2013553","journal-title":"Clin Pharmacol Ther"},{"key":"3673_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2004.07.010","volume":"61","author":"M Bialer","year":"2004","unstructured":"Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T (2004) Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII). Epilepsy Res 61:1\u201348","journal-title":"Epilepsy Res"},{"key":"3673_CR9","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1177\/0091270008319706","volume":"48","author":"L Almeida","year":"2008","unstructured":"Almeida L, Minciu J, Nunes T, Butoianu N, Falc\u00e3o A, Magureanu S-A, Soares-da-Silva P (2008) Pharmacokinetics, efficacy, and tolerability of eslicarbazepine acetate in children and adolescents with epilepsy. J Clin Pharmacol 48:966\u2013977","journal-title":"J Clin Pharmacol"},{"key":"3673_CR10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00228-007-0414-1","volume":"64","author":"L Almeida","year":"2008","unstructured":"Almeida L, Potgieter JH, Maia J, Potgieter MA, Mota F, Soares-da-Silva P (2008) Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment. Eur J Clin Pharmacol 64:267\u2013273","journal-title":"Eur J Clin Pharmacol"},{"key":"3673_CR11","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.saa.2006.12.051","volume":"68","author":"B Hemmateenejad","year":"2007","unstructured":"Hemmateenejad B, Rezaei Z, Khabnadideh S, Saffari M (2007) A PLS-based extractive spectrophotometric method for simultaneous determination of carbamazepine and carbamazepine-10, 11-epoxide in plasma and comparison with HPLC. Spectrochim Acta Part A 68:718\u2013724","journal-title":"Spectrochim Acta Part A"},{"key":"3673_CR12","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00216-006-0724-7","volume":"386","author":"EK Oh","year":"2006","unstructured":"Oh EK, Ban E, Woo JS, Kim C-K (2006) Analysis of carbamazepine and its active metabolite, carbamazepine-10, 11-epoxide, in human plasma using high-performance liquid chromatography. Anal Bioanal Chem 386:1931\u20131936","journal-title":"Anal Bioanal Chem"},{"key":"3673_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1570-0232(01)00590-6","volume":"769","author":"GF Rooyen","year":"2002","unstructured":"Rooyen GF, Badenhorst D, Swart KJ, Hundt HKL, Scanes T, Hundt AF (2002) Determination of carbamazepine and carbamazepine 10, 11-epoxide in human plasma by tandem liquid chromatography\u2013mass spectrometry with electrospray ionisation. J Chromatogr B 769:1\u20137","journal-title":"J Chromatogr B"},{"key":"3673_CR14","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1515\/CCLM.2008.276","volume":"46","author":"C Hunek","year":"2008","unstructured":"Hunek C, Burgyan M, Wang S (2008) Measurement of 10, 11-dihydro-10-hydroxy-carbamazepine in serum and plasma by high-performance liquid chromatography. Clin Chem Lab Med 46:1429\u20131433","journal-title":"Clin Chem Lab Med"},{"key":"3673_CR15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jpba.2006.07.047","volume":"43","author":"V Kimiskidis","year":"2007","unstructured":"Kimiskidis V, Spanakis M, Niopas I, Kazis D, Gabrieli C, Kanaze FI, Divanoglou D (2007) Development and validation of a high performance liquid chromatographic method for the determination of oxcarbazepine and its main metabolites in human plasma and cerebrospinal fluid and its application to pharmacokinetic study. J Pharm Biomed Anal 43:763\u2013768","journal-title":"J Pharm Biomed Anal"},{"key":"3673_CR16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jchromb.2007.10.025","volume":"860","author":"G Paglia","year":"2007","unstructured":"Paglia G, D\u2019Apolito O, Garofalo D, Scarano C, Corso G (2007) Development and validation of a LC\/MS\/MS method for simultaneous quantification of oxcarbazepine and its main metabolites in human serum. J Chromatogr B 860:153\u2013159","journal-title":"J Chromatogr B"},{"key":"3673_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jssc.200700253","volume":"31","author":"L Budakova","year":"2008","unstructured":"Budakova L, Brozmanova H, Grundmann M, Fischer J (2008) Simultaneous determination of antiepileptic drugs and their two active metabolites by HPLC. J Sep Sci 31:1\u20138","journal-title":"J Sep Sci"},{"key":"3673_CR18","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jpba.2008.03.020","volume":"48","author":"RHC Queiroz","year":"2008","unstructured":"Queiroz RHC, Bertucci C, Malfar\u00e1 WR, Dreossi SAC, Chaves AR, Val\u00e9rio DAR, Queiroz MEC (2008) Quantification of carbamazepine, carbamazepine-10, 11-epoxide, phenytoin and phenobarbital in plasma samples by stir bar-sorptive extraction and liquid chromatography. J Pharm Biomed Anal 48:428\u2013434","journal-title":"J Pharm Biomed Anal"},{"key":"3673_CR19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jchromb.2007.06.023","volume":"857","author":"TA Vermeij","year":"2007","unstructured":"Vermeij TA, Edelbroek PM (2007) Robust isocratic high performance liquid chromatographic method for simultaneous determination of seven antiepileptic drugs including lamotrigine, oxcarbazepine and zonisamide in serum after solid-phase extraction. J Chromatogr B 857:40\u201346","journal-title":"J Chromatogr B"},{"key":"3673_CR20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.phrs.2004.09.008","volume":"51","author":"L Franceschi","year":"2005","unstructured":"Franceschi L, Furlanut M (2005) A simple method to monitor plasma concentrations of oxcarbazepine, carbamazepine, their main metabolites and lamotrigine in epileptic patients. Pharmacol Res 51:297\u2013302","journal-title":"Pharmacol Res"},{"key":"3673_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0003-2670(02)00980-7","volume":"472","author":"F Bugamelli","year":"2002","unstructured":"Bugamelli F, Sabbioni C, Mandrioli R, Kenndler E, Albani F, Raggi MA (2002) Simultaneous analysis of six antiepileptic drugs and two selected metabolites in human plasma by liquid chromatography after solid-phase extraction. Anal Chim Acta 472:1\u201310","journal-title":"Anal Chim Acta"},{"key":"3673_CR22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/bmc.117","volume":"16","author":"H Levert","year":"2002","unstructured":"Levert H, Odou P, Robert H (2002) Simultaneous determination of four antiepileptic drugs in serum by high-performance liquid chromatography. Biomed Chromatogr 16:19\u201324","journal-title":"Biomed Chromatogr"},{"key":"3673_CR23","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/bmc.858","volume":"21","author":"G Alves","year":"2007","unstructured":"Alves G, Figueiredo I, Castel-Branco M, Loureiro A, Fortuna A, Falc\u00e3o A, Caramona M (2007) Enantioselective HPLC-UV method for determination of eslicarbazepine acetate (BIA 2-093) and its metabolites in human plasma. Biomed Chromatogr 21:1127\u20131134","journal-title":"Biomed Chromatogr"},{"key":"3673_CR24","unstructured":"US Food and Drug Administration (2001) Guidance for Industry: Bioanalytical method validation. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM070107.pdf"},{"key":"3673_CR25","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1023\/A:1007669411738","volume":"17","author":"VP Shah","year":"2000","unstructured":"Shah VP, Midha KK, Findlay JWA, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT, Yacobi A (2000) Bioanalytical method validation\u2014a revisit with a decade of progress. Pharm Res 17:1551\u20131557","journal-title":"Pharm Res"},{"key":"3673_CR26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1570-0232(02)00244-1","volume":"774","author":"AM Almeida","year":"2002","unstructured":"Almeida AM, Castel-Branco MM, Falc\u00e3o A (2002) Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods. J Chromatogr B 774:215\u2013222","journal-title":"J Chromatogr B"},{"key":"3673_CR27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0378-4347(95)00246-F","volume":"673","author":"P Pienim\u00e4ki","year":"1995","unstructured":"Pienim\u00e4ki P, Fuchs S, Isoj\u00e4rvi J, V\u00e4h\u00e4kangas K (1995) Improved detection and determination of carbamazepine and oxcarbazepine and their metabolites by high-performance liquid chromatography. J Chromatogr B 673:97\u2013105","journal-title":"J Chromatogr B"},{"key":"3673_CR28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0920-1211(01)00231-5","volume":"44","author":"D Hainzl","year":"2001","unstructured":"Hainzl D, Parada A, Soares-da-Silva P (2001) Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(\u2212)-10, 11-dihydro-10-hydroxy carbamazepine. Epilepsy Res 44:197\u2013206","journal-title":"Epilepsy Res"},{"key":"3673_CR29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jchromb.2006.10.031","volume":"847","author":"J Mensch","year":"2007","unstructured":"Mensch J, Noppe M, Adriaensen J, Melis A, Mackie C, Augustijns P, Brewster ME (2007) Novel generic UPLC\/MS\/MS method for high throughput analysis applied to permeability assessment in early Drug Discovery. J Chromatogr B 847:182\u2013187","journal-title":"J Chromatogr B"},{"key":"3673_CR30","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/jms.325","volume":"37","author":"HH Maurer","year":"2002","unstructured":"Maurer HH, Kratzsch C, Weber AA, Peters FT, Kraemer T (2002) Validated assay for quantification of oxcarbazepine and its active dihydro metabolite 10-hydroxycarbazepine in plasma by atmospheric pressure chemical ionization liquid chromatography\/mass spectrometry. J Mass Spectrom 37:687\u2013692","journal-title":"J Mass Spectrom"},{"key":"3673_CR31","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jchromb.2007.04.006","volume":"854","author":"C Greiner","year":"2007","unstructured":"Greiner C, Haen E (2007) Development of a simple column-switching high-performance liquid chromatography (HPLC) method for rapid and simultaneous routine serum monitoring of lamotrigine, oxcarbazepine and 10-monohydroxycarbazepine (MHD). J Chromatogr B 854:338\u2013344","journal-title":"J Chromatogr B"},{"key":"3673_CR32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jpba.2005.02.045","volume":"39","author":"KM Patil","year":"2005","unstructured":"Patil KM, Bodhankar SL (2005) Simultaneous determination of lamotrigine, phenobarbitone, carbamazepine and phenytoin in human serum by high-performance liquid chromatography. J Pharm Biomed Anal 39:181\u2013186","journal-title":"J Pharm Biomed Anal"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-010-3673-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-010-3673-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-010-3673-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:46:57Z","timestamp":1558644417000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-010-3673-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,18]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["3673"],"URL":"https:\/\/doi.org\/10.1007\/s00216-010-3673-0","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,18]]}}}